Opinion: It’s time for a new moonshot — and it should be focused on proteomics, a space where China is already investing ...

The last decade has seen a swell of biotech startups using AI to design proteins. These are seven companies to watch.

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Eponyms — diseases named after a person — can cause serious confusion. That is particularly true in one rare disease ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.

WASHINGTON — A second Trump presidency could mean significant changes to health care access and costs, even if former ...

Hospitals ask for more cash at the Supreme Court, changing Medicare Advantage rules, health care CEOs' political donations.

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

Their discoveries have already led to the departure of a Stanford president, sparked charges from the Department of Justice, ...

Under names like “Patriot Plan,” private Medicare Advantage plans are courting veterans even as the VA covers most care.

When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market, but that process can take a while.